The induction of molecular genetic conversion in bone marrow (BM) in Patients with indolent Lymphomas Treated by Mnoclonal Antibody anti-CD20 (MABTHERA)

Abstract

Patients with indolent lymphomas were tested by PCR before and after therapy with monoclon antiCD20 (MABTHERA)